Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Nonprofit Organization ‘The ElleVet Project’ Releases New Video Detailing their Work


The ElleVet Project by ElleVet Sciences was founded in 2020 by Amanda Howland and Christian Kjaer in response to the COVID-19 pandemic. They recognized the need for veterinary care amongst the homeless populations as they would now had fewer resources than ever due to the global crisis. In an effort to reduce the death toll for street pets, the co-founders rented a 38 foot RV which they converted into a mobile vet clinic.

The first two months of this project proved to be massively successful as they were able to treat over 1200 pets. The co-founders recognized the overwhelming need for veterinary care for this vulnerable population and decided to turn the ElleVet Project into a permanent philanthropic organization. Since the launch in 2020, the ElleVet Project has expanded to more cities and states and has treated thousands and thousands of pets of the unhoused, including emergency lifesaving surgeries.

Their latest video content showcases what the ElleVet Project has been up to over the past few years. It includes interviews with the co-founders in addition to interviews with some of the pet owners who have benefited from ElleVet’s care. ElleVet also gives an exclusive look at their mobile veterinary center.

Also covered in the new video is the work that ElleVet did for hurricane Ian in Florida. “As we watched the coverage of hurricane Ian, my mind kept going to all the animals that were going to be lost,” said Howland. She went on to say that they “headed down as fast as we could to Florida to go where we were needed” as soon as the storm hit. The ElleVet Project is proud of their work in Florida and wishes to keep expanding so they can go wherever they are needed, whenever they are needed.

Find out more by watching the new video detailing ElleVet’s recent work here. You can also go to their website for more information on the organization or for information on how to donate.

###

About The ElleVet Project: The ElleVet Project was established to help provide veterinary care to the unhoused populations in major cities. They have goals to expand the project until they are able to provide care for pets in each state and every part of the country where they are needed.

Share article on social media or email:

Regionals Southeast List for the 2nd Year in a Row


“I can’t say enough about how proud I am of our team’s ability to serve our innovative health plan clients with a technology platform that’s transforming payment accuracy.”

Inc. magazine today revealed that ClarisHealth ranked for the second year in a row on its third annual Inc. 5000 Regionals: Southeast list, the most prestigious ranking of the fastest-growing Southeast private companies, based in Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Mississippi, Puerto Rico, South Carolina, and Tennessee. ClarisHealth, the leading provider of an enterprise payment integrity platform for health plans Pareo, attributes its sustained revenue hyper-growth to an industry shift toward innovation.

According to ClarisHealth chief executive officer https://www.clarishealth.com/about-us/leadership/Jeff McNeese, payment integrity has been rising to a more strategic function at health plans, who seek to control the cost of healthcare by reducing improperly paid healthcare claims. Clients that implement Pareo accelerate improvements in healthcare claims payment accuracy.

“I can’t say enough about how proud I am of our team’s ability to serve our innovative health plan clients with a technology platform that’s transforming payment accuracy,” says McNeese. “It’s one thing to grow. It’s quite another to grow on this trajectory with consistency, especially in challenging times. But working together, we’re achieving incredible results.”

Born of the annual Inc. 5000 franchise, this regional list represents a unique look at the most successful companies within the Southeast economy’s most dynamic segment–its independent small businesses. Between 2019 and 2021, these private companies had an average growth rate of 673-percent and, in 2021 alone, they added 25,844 jobs and nearly $7 billion to the Southeast region’s economy.

“This year’s Inc. 5000 Regional winners represent one of the most exceptional and exciting lists of America’s off-the-charts growth companies,” said Scott Omelianuk, editor-in-chief of Inc. magazine. “They’re disrupters and job creators, and all delivered an outsize impact on the economy. Remember their names and follow their lead. These are the companies you’ll be hearing about for years to come.”

This ranking is the latest recognition of ClarisHealth’s hypergrowth. In 2022, it ranked on the Inc. 5000 for the third year running and on the Deloitte Technology Fast 500 for the second year in a row. Its enterprise technology platform Pareo has been included as a sample vendor for prospective payment integrity by the Gartner Hype Cycle for U.S. Payers.

The companies on this list show a remarkable rate of growth across all industries in the Southeast region. Complete results of the Inc. 5000 Regionals: Southeast, including company profiles and an interactive database that can be sorted by industry, metro area, and other criteria, can be found at inc.com/southeast.

About ClarisHealth

ClarisHealth, an Inc. 5000 and Deloitte Technology Fast 500 company and recognized as for prospective payment integrity solutions in the Gartner Hype Cycle, provides health plans and payers with the industry’s leading payment integrity operating system. Its proprietary, A.I.-powered enterprise technology platform Pareo® enables health plans to maximize cost avoidance and recoveries at the most optimized cost for a 10x return on their software investment.

More about Inc. and the Inc. 5000 Regionals Methodology

The 2023 Inc. 5000 Regionals are ranked according to percentage revenue growth when comparing 2019 and 2021. To qualify, companies must have been founded and generating revenue by March 31, 2019. They had to be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2021. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2019 is $100,000; the minimum for 2021 is $1 million. As always, Inc. reserves the right to decline applicants for subjective reasons.

About Inc. Media

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit http://www.inc.com.

Share article on social media or email:

Exclusive Screening of Below The Belt in Vancouver BC


Below the Belt

Below the Belt

The film follows the personal and inspiring stories of four patients urgently searching for answers to mysterious symptoms and exposes widespread problems in our healthcare systems.

The highly anticipated documentary, “Below the Belt,” will be screened in Vancouver on April 19th at the Jewish Community Centre of Greater Vancouver. March is Endometriosis Awareness Month and Acubalance Wellness Centre, Olive Fertility, and Jane are the proud hosts of this exclusive screening.

“Below the Belt” is executive produced by Hillary Rodham Clinton, Rosario Dawson, Corinne Foxx, and Mae Whitman.

The film follows the personal and inspiring stories of four patients urgently searching for answers to mysterious symptoms and exposes widespread problems in our healthcare systems.

Through the lens of endometriosis, a disease that affects 1 in 9 women, the film shows how women are often dismissed, discounted & disbelieved. From societal taboos and gender bias to ineffective drugs and surgeries, women are erroneously told that pregnancy and hysterectomy are cures. Nearly 50% of infertility cases are due to endometriosis and almost all are preventable. This film reveals how millions are effectively silenced and how, by fighting back, they can improve healthcare for everyone.

The screening will be followed by a Q&A with several special guests, Roop Bassra, RN (endointhe604.com), Kali MacIsaac, ND (Acubalance Wellness Centre), Allison Locke, RTCMP (Acubalance Wellness Centre), Paul Yong, MD, PhD, FRCSC (Endometriosis & Pelvic Pain Lab), Beth Taylor, MD, FRCSC (Olive Fertility), Trish Gipson, MSc (Pelvic Floor Physiotherapy), Lorne Brown, DrTCM (Acubalance Wellness Centre).

Tickets are available now at http://www.acubalance.ca/endo.

Share article on social media or email:

OpenClinica Maintains Effective Security Controls According to SOC 2 Report


As stewards of sensitive healthcare data, security is foundational to everything we do.

Today, OpenClinica announced the company successfully completed a System and Organization Controls (SOC) 2 examination. The examination and audit was carried out by an independent third-party CPA firm and underscores OpenClinica’s ongoing commitment to effective controls over the security, availability, processing integrity, confidentiality and privacy of its electronic data capture platform. A SOC 2 report is designed to meet the needs of existing or potential customers seeking assurance about the effectiveness of controls used by the service organization to process customer information.

“The SOC 2 process verifies we have the appropriate controls in place to mitigate risks related to security, availability, processing integrity, confidentiality and privacy of the data entrusted to us,” said Cal Collins, company co-founder and CEO. “As stewards of sensitive healthcare data, security is foundational to everything we do.”The following principles and related criteria were developed by the American Institute of CPAs (AICPA) for use by practitioners in the performance of trust services engagements:


  • Security: The system is protected against unauthorized access both physical and logical.
  • Availability: The system is available for operation and use as committed or agreed.
  • Processing Integrity: System processing is complete, valid, accurate, timely and authorized to meet the entity’s objectives.
  • Confidentiality: Information designated as confidential is protected as committed or agreed.
  • Privacy: Personal information is collected, used, retained, disclosed and disposed of to meet the entity’s objectives.

A SOC 2 report is an internal control report on the services provided by a service organization to its customers and provides valuable information that existing and potential customers of the service organization need to assess and address the risks associated with an outsourced service. Current and prospective customers interested in a copy of the SOC 2 report may contact Laura Keita, Senior Director, Compliance at lkeita@openclinica.com.

About OpenClinica

OpenClinica accelerates clinical trials by automating data acquisition through its software-as-a-service platform. Offering a secure bridge between healthcare and research, OpenClinica is trusted by the world’s foremost life science companies, academic institutions, and government entities and has been used in more than 10,000 studies involving over five million patients. OpenClinica is proud to support hundreds of small, midsize and large research organizations spanning biotech, pharma, medical device manufacturing and contract research organizations. Learn more at openclinica.com or email us at betterdata@openclinica.com

Share article on social media or email:

Boston University’s Pregnancy Study Online (PRESTO) Expands with Remote Microsampling by Trajan


“Blood sample analysis is a key component of the E-PRESTO study, and remote Mitra® devices from Trajan enable us to offer convenient at-home blood sampling to a larger study cohort of couples who live across the United States,” said Lauren Wise, ScD, BU School of Public Health.

The Pregnancy Study Online (PRESTO) at Boston University, which investigates environmental influences on fertility and miscarriage, expanded its protocol this year to offer at-home biospecimen collection to participants across 48 states. The PRESTO research team is conducting a sub-study called the Environmental Pregnancy Study Online (E-PRESTO), using biospecimen analysis to learn if certain chemicals in the environment are harmful to reproductive health. To encourage participation of couples across a wider geographical area, the researchers are offering a mail-based E-PRESTO option, shipping sampling kits to participants’ homes. Trajan’s Mitra® devices are included in the mailed kits for remote self-collection of blood samples using a quick finger-prick method. The kits also include collection cups to facilitate urine collection at home. All samples are mailed back to BU for storage and analysis at various external laboratories over the next 2 years. After analysis, participants receive a report of their exposure to chemicals and how to reduce exposure levels.

“Our early study results revealed that several socio-demographic and lifestyle factors (e.g., short sleep duration, greater intake of sugar-sweetened beverages, obesity, stress) can hinder conception. In addition, there is growing evidence that certain chemicals in the environment adversely affect fertility and healthy pregnancy, yet there has been less research on the effects of environmental chemicals,” said Lauren Wise, ScD, professor of epidemiology and principal investigator of the School of Public Health-based PRESTO at Boston University.

The team received additional NIH funding to launch the E-PRESTO sub-study to examine potential environmental effects among PRESTO participants. Analytes of interest for E-PRESTO include endocrine disrupting chemicals (e.g., PFAS, PCBs, phthalates, phenols, heavy metals), and vitamin D. The mail-based protocol helps the team reach more volunteers.

“Blood sample analysis is a key component of the E-PRESTO study, and remote Mitra® devices from Trajan enable us to offer convenient at-home blood sampling to a larger study cohort of couples who live across the United States,” said Dr. Wise.

The E-PRESTO researchers encourage study participants in the Boston or Detroit areas to participate in traditional venipuncture blood draws in their respective clinics. E-PRESTO participants living outside those areas can receive mailed kits containing the remote Mitra devices and other sampling supplies. The Mitra devices are designed to allow virtually anyone, anywhere to collect a precise blood sample for mailing to a designated lab for analysis.

If interested in the E-PRESTO sub-study, visit the web page: E-PRESTO | PRESTO (English Language Version) (bu.edu). To enroll in PRESTO & E-PRESTO, click on the study invitation link or contact the BU research team at: bupresto@bu.edu or 617-358-3424.

About Trajan Scientific and Medical & Neoteryx Microsampling Solutions by Trajan

Neoteryx, a leader in microsampling devices, was acquired by Trajan in 2021. Today, Trajan’s full line of Neoteryx microsampling solutions provide precise, quantitative remote specimen collection. They are easy to use and amenable to automated analysis in the lab, easing workflows and enabling decentralized research and healthcare models. Products include the Mitra® device based on VAMS® technology and the hemaPEN® that advances capillary and dried blood spot (DBS) technologies, with more microsampling products in the pipeline. For more information on Trajan’s Neoteryx range of microsampling solutions, visit http://www.neoteryx.com or http://www.trajanscimed.com.

# # #

Jillian P. McKoy, MPH, Sr. Writer/Editor, BU Office of Communications and Marketing

(617) 358-3453, jpmckoy@bu.edu

Share article on social media or email:

One Young Man’s Quest to Realize His Dream of Helping Others Through Blood Donation


News Image

I was shocked that in the year 2023, an otherwise healthy individual was denied donating much-needed blood simply because he needed minimal assistance to get up on the donation bed

According to The Arc (1), people living with a disability face discrimination, segregation, and exclusion from education, employment, community living, and routine daily activities.

Fortunately, Matthew, a young adult living in Florida, isn’t one to put up with being excluded. Matthew turned 16 in February and had big plans to celebrate by giving blood for the first time. As a lifelong Tampa Bay Lightning fan and big-time Victor Hedman fan, Matthew hoped to encourage 77 others to join him in honor of his hockey hero, who wears the #77 jersey.

Unfortunately, when he arrived at the blood collection center in his community on his birthday along with 20-25 of his supporters and prospective donors, he was told people who couldn’t independently get up on the donor bed couldn’t donate because of a Food and Drug Administration (FDA) requirement. Matthew, who has cerebral palsy, uses a wheelchair and can assist in transfers but needs a little help to get there.

“I was discouraged and sad because I had waited for years for this moment. Everyone there knew I was in a wheelchair before I got there. It wasn’t nice for them to deny me saving lives when I was ready and able to donate my blood,” said Matthew.

Matthew, his mother, and his former teacher and IntellectAbility Inside Sales Representative, Grace Gould, knew this wasn’t right. “I was shocked that in the year 2023, an otherwise healthy individual was denied donating much-needed blood simply because he needed minimal assistance to get up on the donation bed,” said Grace. “What about the organization’s responsibility for complying with the ADA (Americans with Disabilities Act)?”

They researched blood donation regulations, sent emails and received confirmation from the FDA’s Office of Blood Research and Review (OBRR) that there are no federal rules about one’s ability to independently get on or off the blood donation bed. Armed with this information, they returned to the blood collection center, which reconsidered its previous decision and issued a policy clarification referred to as “Matthew’s Memo,” indicating people can be assisted by their own supporters onto the donation bed. And as soon as the mandatory waiting period after being rejected as a donor is up, Matthew plans to be there, front and center, to donate.

“We applaud Matthew, his parents, and his supporters for their perseverance. And we encourage others to advocate for people with disabilities. And, as we celebrate National Cerebral Palsy Month, we recognize and salute the countless direct supporters who work to advocate for and enhance the lives of people with disabilities every day,” said Dr. Craig Escudé, IntellectAbility President.

To learn more about Matthew, click here https://replacingrisk.com/matthews-memo-an-advocacy-success-story/

About IntellectAbility

IntellectAbility provides tools and training to agencies, governmental entities, and supporters of people with intellectual and developmental disabilities to foster early recognition and mitigation of health risks, thereby improving health and wellness. One such tool is the Health Risk Screening Tool (HRST), of which they are the sole developer, producer, and distributor. The web-based HRST is the most widely used and validated health risk screening instrument for people with intellectual and developmental disabilities. IntellectAbility also provides numerous health-related and person-centered service training for supporters of people with IDD. With an unrelenting focus, IntellectAbility works to fulfill its mission of improving health and quality of life for people with intellectual and developmental disabilities and other at-risk populations. For more information, visit http://www.ReplacingRisk.com.

Source:

1) The Arc. 2023. https://thearc.org/about-us/mission-values/

Share article on social media or email:

The Luna Prenatal Test for Isolation of Circulating Fetal Cells Early in Pregnancy, Upcoming Webinar Hosted by Xtalks


Various genetic abnormalities were detected by the Luna Prenatal Test over the course of the study, including common trisomies, rare autosomal trisomies, microdeletions, microduplications and confined placental mosaicism.

For decades, many groups around the world have pursued the isolation and genetic analysis of circulating fetal cells from maternal peripheral blood as an improved form of noninvasive prenatal testing. However, the exceeding rarity of these cells in the blood of pregnant women has proven a challenging obstacle in the establishment of a reliable test methodology.

Luna Genetics has overcome this challenge using a unique combination of robust immunostaining, microfluidic enrichment, automated microscopy and single cell isolation. The noninvasive prenatal testing method was validated with over 200 high-risk cases undergoing chorionic villus sampling (CVS) or amniocentesis, along with 158 low-risk cases not undergoing CVS or amniocentesis. The Luna Prenatal Test showed near-perfect concordance with the CVS and amniocentesis results, and the few discordant cases were consistent with current knowledge of confined placental mosaicism. Various genetic abnormalities were detected by the Luna Prenatal Test over the course of the study, including common trisomies, rare autosomal trisomies, microdeletions, microduplications and confined placental mosaicism.

Furthermore, the Luna Prenatal Test methodology has been successfully applied to the identification of recessive monogenic disorders. In collaboration with Juno Genetics, the Luna Prenatal Test isolated circulating fetal cells from a pregnancy at risk of Walker-Warburg Syndrome. The cells were shipped overnight to Juno Genetics for sequencing and haplotype-based analysis of the POMT1 gene. The fetus was determined to be an unaffected heterozygous carrier of the POMT1 c.2167dupG allele, with concordant CVS results reported 10 days later. This case study demonstrates proof-of-concept for the application of the Luna Prenatal Test in detecting monogenic disorders early in pregnancy.

Register today to learn about a breakthrough in the reliable isolation and successful analysis of circulating fetal cells for noninvasive prenatal testing early in pregnancy. The webinar will include the path taken to establish the Luna Prenatal Test methodology, data from key validation cases and the future trajectory of the test.

Disclaimer: Namocell products are for research use only; not for diagnostic purposes.

Join Mason Ouren, R&D Scientist, Luna Genetics, for the live webinar on Friday, March 17, 2023, at 2pm EDT (11am PDT).

For more information, or to register for this event, visit Noninvasive Prenatal Testing: The Luna Prenatal Test for Isolation of Circulating Fetal Cells Early in Pregnancy.

Registrants will be provided with on-demand access to the webinar recording after the event.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Clinical Research as a Care Option Organized by the Conference Forum Announces Keynote and Key Topics for the 7th Annual Meeting


“I am looking forward to the 2023 CRAACO event as it is so important to explore ‘how’ clinical research can work with community hospitals,” said Madeline Sparks Cresswell, MBA, Research Program Manager – OHSU Health, Clinical Research Services Office (CRSO), Oregon Health & Science University.

The Conference Forum announced the launch of the 7th annual CRAACO®: Clinical Research as a Care Option conference, with the 2023 keynote and key topics. The meeting will take place May 22-23, 2023 at the Sheraton Imperial Hotel Raleigh-Durham Airport at Research Triangle Park, in Raleigh-Durham, NC.

“Embedding clinical research in the care setting can lead to higher rates of clinical trial participation inside of a health system, better health outcomes, lower cost of care and more satisfied patients,” said Jennifer Byrne, Founder, Board Member and CEO, Javara.

The CRAACO 2023 keynote, Julie Freischlag, MD, will be speaking on the future of integrated health. Dr Freischlag is CEO of Atrium Health Wake Forest Baptist, Chief Academic Officer and Executive Vice President, Advocate Health, and Executive Vice President for Health Affairs, Wake Forest University.

“CRAACO is the only conference that examines how we can integrate care and research to give many more patients access to clinical research,” said Valerie Bowling, Executive Director, Conference Forum.

Featured sessions include:

  • Evaluating and Strategizing the Financial Economics of Clinical Care in the Research Setting
  • Enabling All Care Locations to be Research Locations
  • Strategies for Building a Successful Clinical Research Team in the Care Setting
  • How Merck Increased Minority Representation in its Clinical Research Staff
  • Applying Digital Innovation to Streamline Clinical Research in the Care Setting for the Improvement of the Patient Experience
  • How Sanofi is Partnering with Hospital Systems to Leverage EHRs for Patient Matching from Care to Research

“I am looking forward to the 2023 CRAACO event as it is so important to explore ‘how’ clinical research can work with community hospitals,” said Madeline Sparks Cresswell, MBA, Research Program Manager – OHSU Health, Clinical Research Services Office (CRSO), Oregon Health & Science University.

Key topics for 2023 include:

  • The business case for CRAACO
  • Patients first
  • Democratizing access and connecting the ecosystem
  • Community integration
  • Workforce issues in clinical research
  • Integrating digital innovation
  • EHRs & data from care to research

To learn more about the event and to read the full agenda, please visit craacoevent.com.

About CRAACO®: Clinical Research as a Care Option

The Clinical Research as a Care Option event (CRAACO) is the first conference dedicated to bringing together health systems, pharma, patients, regulators and innovators to address the value, challenges and success stories of integrating clinical research options in the clinical care space for the benefit of patients.

About the Conference Forum

The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused.

They currently offer conferences for pharma/biotech professionals including R&D leaders, CEOs, business development/licensing, medical affairs/safety, chief patient officers/advocates, clinical innovation champions, investors and drug delivery specialists. The company also publishes six newsletters and produces PharmaTalkRadio and virtual events.

Share article on social media or email:

Origins Counseling Center in Dallas Launches Mental Health Intensive Outpatient Program


Stigma around mental health concerns prevents many individuals from seeking the help they need. Like any health concern, mental health can improve with treatment.

Origins Counseling Center in Dallas, Texas, will open its new Mental Health Intensive Outpatient Program (IOP) on March 6, 2023. This valuable new program will meet the critical need for outpatient services for individuals with mental health disorders. Clinical Director Shea Barakatt, MA, LCSW, LCDC, understands mental health’s impact on adults and their family systems.

“Mental health is just as important as physical health. If one of these elements is ignored, it can affect the whole person. Beyond that, untreated mental health symptoms can dramatically impact a person’s social relationships, job or academic performance, and family system,” says Barakatt. “By acknowledging and addressing mental health concerns, people from all walks of life can learn valuable tools to help them find improved self-esteem and reach their highest potential.”

The new Mental Health IOP framework at Origins Counseling Center in Dallas offers a sophisticated in-network treatment option for individuals with mental health concerns who want to amplify their healing process. While individual therapy can be a powerful resource, coupling this with intensive group therapies can help people with mental health disorders develop a network of lasting, peer-driven support. Mental Health IOP is a good option for those who are psychiatrically stable or recently discharged from a residential psychiatric treatment program and want the continued support and motivation provided by group therapy sessions.

Origins’ compassionate therapists and counselors help identify and treat a wide range of mental health disorders, including depression, borderline personality disorder (BPD), anxiety, mood disorders, bipolar disorders, trauma and post-traumatic stress disorders (PTSD), adjustment disorders, grief and loss, obsessive-compulsive disorders, process addictions, and more. These masters-level clinicians leverage evidence-based modalities such as Dialectical Behavior Therapy (DBT), Cognitive Behavior Therapy (CBT), psychoeducation, biofeedback, Eye-Movement Desensitization and Reprocessing (EMDR), and expressive arts therapy.

Patients are surrounded three days a week by an empathetic group of clinical professionals. Therapists help patients learn coping mechanisms and practical strategies to use when they feel overwhelmed to help improve their quality of life. Origins’ Mental Health IOP offers a chance to gain emotional stability in a safe, supportive environment while carefully monitoring patients’ progress. The program accepts insurance and is in-network with Blue Cross and Blue Shield of Texas.

“Stigma around mental health concerns prevents many individuals from seeking the help they need. Like any health concern, mental health can improve with treatment,” says Barakatt. “We want our patients to know that there is hope and that healing is possible for them. We are honored to be able to expand our services to this realm and, in the process, help to lessen the stigma surrounding mental health.”

Patients in the Mental Health IOP will learn vital coping skills to help navigate work-related stress and burnout, the challenges of parental, family, and social relationships, financial pressures, grief and loss, and other medical diagnoses and health concerns. The goal is for individuals to gain a newfound sense of self-worth, direction, and control that they can bring into every aspect of their lives.

Call Origins Counseling Center’s Mental Health IOP at 855.741.4673 or fill out our online contact form: originscounselingdallas.com/contact-us/.

About Origins Behavioral HealthCare

Origins Behavioral HealthCare offers a range of treatment programs targeting recovery from substance use, mental health issues, and beyond. Our primary mission is to provide a clear path to a life of healing and restoration. We offer renowned clinical care for addiction and mental health concerns and have the compassion and professional expertise to guide you toward healing. Visit OriginsRecovery.com or call 855.741.4673.

About Origins Counseling Center in Dallas

Origins Counseling Center, based in Dallas, Texas, offers outpatient addiction and mental health treatment for men, women, and families. We serve everyone—from business professionals and stay-at-home moms to young college students. With compassion and expertise, our gifted therapists can empower you with the tools you need to embrace a whole, healthy life. Our team uses evidence-based therapies and interventions for substance use, mental health, and co-occurring disorders, and we develop personalized treatment plans for each patient. Visit OriginsCounselingDallas.com or call 855.741.4673.

Share article on social media or email: